Shamsul Idham Bin A. Iahad

Chief Executive Officer, Duopharma Consumer Healthcare Sdn. Bhd.


49 years




  • Diploma in Business Studies, MARA Institute of Technology, Malaysia
  • Bachelor of Science (Marketing), University of Bridgeport, Connecticut, United States of America
  • Managerial Finance from The London School of Economics and Political Science, England

Working Experience and Occupation

Shamsul joined Duopharma Marketing Sdn. Bhd. as Senior Manager in February 2012, responsible for the Over-the-counter (“OTC”) Marketing Department and the Events & Promotions Department. He was later promoted to General Manager in April 2017, responsible for OTC Business with Sales, Marketing, Events & Promotions and Indonesia business portfolios. Following the Group’s new business strategy, Shamsul has been appointed to helm Duopharma Consumer Healthcare Sdn. Bhd. as its Chief Executive Officer. Duopharma Consumer Healthcare Sdn. Bhd., a wholly-owned subsidiary of Duopharma Biotech, engages in consumer healthcare business in Malaysia and ASEAN in January 2020. Beginning January 2021, he has taken up the additional responsibility of leading the Corporate Communication functions in the Group.

In 2009, he assumed the dual roles of Sales & Marketing Manager of Sanofi-Aventis (Malaysia) Sdn. Bhd., responsible for the Consumer Healthcare business for both Malaysia and Singapore; and leading in the business’ transformation to become consumer-driven as opposed to being pharma-centric. The objective was to grow the consumer healthcare business.

Shamsul has more than 20 years of experience in sales and marketing of consumer healthcare as well as fast-moving consumer goods (FMCG) brands. He has previously managed brands such as Magnolia ice-cream, Sensodyne, Aquafresh, Appeton, Lactacyd and Essentiale. He is a member of Duopharma Biotech’s Group Management Committee.